pubmed-article:16421920 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C1622968 | lld:lifeskim |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C0001779 | lld:lifeskim |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C0005558 | lld:lifeskim |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C1744620 | lld:lifeskim |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C0008902 | lld:lifeskim |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C1704711 | lld:lifeskim |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:16421920 | lifeskim:mentions | umls-concept:C0028275 | lld:lifeskim |
pubmed-article:16421920 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:16421920 | pubmed:dateCreated | 2006-2-23 | lld:pubmed |
pubmed-article:16421920 | pubmed:abstractText | A survey of the distribution of human papillomavirus (HPV) types across the spectrum of cervical cytologic categories defined by the Bethesda 2001 guidelines was conducted with the objective of examining how HPV detection by polymerase chain reaction (PCR) analysis may benefit the management of patients who have abnormal Papanicolaou (Pap) test results. | lld:pubmed |
pubmed-article:16421920 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16421920 | pubmed:language | eng | lld:pubmed |
pubmed-article:16421920 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16421920 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16421920 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16421920 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16421920 | pubmed:month | Mar | lld:pubmed |
pubmed-article:16421920 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:16421920 | pubmed:author | pubmed-author:CooperKumaras... | lld:pubmed |
pubmed-article:16421920 | pubmed:author | pubmed-author:PapilloJacaly... | lld:pubmed |
pubmed-article:16421920 | pubmed:author | pubmed-author:LeimanGladwyn... | lld:pubmed |
pubmed-article:16421920 | pubmed:author | pubmed-author:EvansMark FMF | lld:pubmed |
pubmed-article:16421920 | pubmed:author | pubmed-author:AdamsonChrist... | lld:pubmed |
pubmed-article:16421920 | pubmed:author | pubmed-author:St... | lld:pubmed |
pubmed-article:16421920 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16421920 | pubmed:day | 1 | lld:pubmed |
pubmed-article:16421920 | pubmed:volume | 106 | lld:pubmed |
pubmed-article:16421920 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16421920 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16421920 | pubmed:pagination | 1054-64 | lld:pubmed |
pubmed-article:16421920 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:meshHeading | pubmed-meshheading:16421920... | lld:pubmed |
pubmed-article:16421920 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16421920 | pubmed:articleTitle | Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. | lld:pubmed |
pubmed-article:16421920 | pubmed:affiliation | Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont 05405, USA. mark.evans@uvm.edu | lld:pubmed |
pubmed-article:16421920 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16421920 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16421920 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16421920 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16421920 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16421920 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16421920 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16421920 | lld:pubmed |